Showing results (581-590 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|June 30, 2011
CK2 inhibitors enhance the radiosensitivity of human non-small cell lung cancer cells through inhibition of stat3 activationYu-Ching Lin, Ming-Szu Hung, Chin-Kuo Lin, et al.Cancer Biotherapy & Radiopharmaceuticals|August 13, 2011
RGD-modified endostatin peptide 30 derived from endostatin suppresses invasion and migration of HepG2 cells through the αvβ3 pathwayShuyan Li, Jing Wei, Lijie Yuan, et al.Cancer Biotherapy & Radiopharmaceuticals|August 13, 2011
Chemoradionuclide therapy with 186re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic responseAnuradha Soundararajan, Ande Bao, William T Phillips, et al.Cancer Biotherapy & Radiopharmaceuticals|August 25, 2011
Photodynamic therapy using an anti-EGF receptor antibody complexed with verteporfin nanoparticles: a proof of concept studyNoriaki Kameyama, Sachiko Matsuda, Osamu Itano, et al.Cancer Biotherapy & Radiopharmaceuticals|August 12, 2011
Mitochondrial gene expression in directly irradiated and nonirradiated bystander cellsM Ahmad Chaudhry, Romaica A OmaruddinCancer Biotherapy & Radiopharmaceuticals|August 5, 2011
Efficacy of large doses of IL-2-activated human leukocyte antigen haploidentical peripheral blood stem cells on refractory metastatic renal cell carcinomaShui Cao, Yun-Liang Wang, Xiu-Bao Ren, et al.Cancer Biotherapy & Radiopharmaceuticals|August 5, 2011
Efficient in vitro labeling of human prostate cancer cells with superparamagnetic iron oxide nanoparticlesJun Jiang, Yaqing Chen, Yunkai Zhu, et al.Cancer Biotherapy & Radiopharmaceuticals|September 3, 2011
[99mTc]demotensin VI: biodistribution and initial clinical results in tumor patients of a pilot/phase I studyMichael Gabriel, Clemens Decristoforo, Ewald Wöll, et al.Cancer Biotherapy & Radiopharmaceuticals|September 3, 2011
Role of inhibitor of apoptosis protein Livin in radiation resistance in nonsmall cell lung cancerJian-Guo Sun, Rong-Xia Liao, Shao-Xiang Zhang, et al.Cancer Biotherapy & Radiopharmaceuticals|September 24, 2011
Comparison of I-131 radioimmunotherapy tumor dosimetry: unit density sphere model versus patient-specific Monte Carlo calculationsDavid M Howard, Kimberlee J Kearfott, Scott J Wilderman, et al.Pageof 223